In this report, the authors summarize updated results with adjuvant immunotherapy with bacillus Calmette-Guerin (BCG) for patients with recurrent malignant melanoma. This program was initiated in 1971.
|Title of host publication||Recent Results in Cancer Research|
|Number of pages||4|
|State||Published - Dec 1 1979|
ASJC Scopus subject areas